SCHEMBL4755233

SCHEMBL4755233

O=C1NC=COC1c1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.40
MGLL Q99685 1/20 0.33
GSK3B P49841 2/20 0.32
BACE1 P56817 2/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
MDM2 Q00987 2/20 0.31
MAOB P27338 4/20 0.30
CYP19A1 P11511 1/20 0.30
LIG1 P18858 1/20 0.30
MMP1 P03956 1/20 0.30
MMP13 P45452 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28890875 0.81 CA2 (0.47) KMT2ASMN1; SMN2CA2
SCHEMBL11040315 0.67 CA2 (0.67) TDP1MGLLGSK3BBACE1KMT2A
SCHEMBL15529908 0.62
SCHEMBL174752 0.60 MAOB (0.36) TDP1GSK3BBACE1KMT2ASMN1; SMN2
SCHEMBL9046538 0.59 GSK3B (0.42) TDP1GSK3BBACE1KMT2ASMN1; SMN2
SCHEMBL18873952 0.59 TDP1 (0.50) TDP1MGLLGSK3BBACE1KMT2A
SCHEMBL2893585 0.58 MAOB (0.44) TDP1MAOB
SCHEMBL15071304 0.58 MAOB (0.34) TDP1MAOBCYP19A1LIG1
SCHEMBL5021254 0.58 MAOB (0.44) TDP1MAOB
SCHEMBL9244468 0.58 FADS1 (0.42) TDP1MAOBCYP19A1LIG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001203-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2008-12-31 WO disclosed
EP-1112259-A4 PROCESS FOR THE SYNTHESIS OF N-BENZYL-3-(4-FLUOROPHENYL)-1,4-OXAZIN-2-ONE MERCK & CO INC (US) 2002-01-09 EP disclosed
EP-1112259-A1 PROCESS FOR THE SYNTHESIS OF N-BENZYL-3-(4-FLUOROPHENYL)-1,4-OXAZIN-2-ONE Merck & Co., Inc. (a New Jersey corp.) (US) 2001-07-04 EP disclosed
WO-2000015621-A1 PROCESS FOR THE SYNTHESIS OF N-BENZYL-3-(4-FLUOROPHENYL)-1,4-OXAZIN-2-ONE MERCK & CO., INC. (US) 2000-03-23 WO disclosed